Source: Health Canada shortage reports · Updated Jul 9, 2026
Alirocumab has no current shortage reported in Canada. It has been in shortage before; the history is below.
A PCSK9 inhibitor used to lower high cholesterol.
Products affected
0 / 2
Reports on file
14
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
PRALUENT
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453835 · ended Feb 6, 2026
Resolved
PRALUENT
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453835 · ended Jun 5, 2024 · Manufacturing Delay
Resolved
PRALUENT
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453835 · ended Dec 22, 2023
Resolved
PRALUENT
75MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453819 · ended Dec 22, 2023
Resolved
PRALUENT
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453835 · ended May 31, 2023 · Manufacturing delay.
Resolved
PRALUENT
75MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453819 · ended Feb 2, 2023
Resolved
PRALUENT
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453835 · ended Jan 26, 2023
Resolved
PRALUENT
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453835 · ended Dec 22, 2022 · Demand increase for the drug.
Resolved
PRALUENT
75MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453819 · ended Nov 8, 2021
Resolved
PRALUENT
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453835 · ended May 3, 2021 · A manufacturing delay may create a short term shortage. Supplies are expected by early May, shortage should be avoided as allocation will be put in place.
Resolved
PRALUENT
150MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453835 · ended May 9, 2019
Resolved
PRALUENT
75MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02453819 · ended Apr 17, 2019
Showing 12 of 14 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Alirocumab. Health Canada has 14 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Alirocumab is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AX).
Recent changes
No changes recorded yet.
Common questions
What is Alirocumab used for?
A PCSK9 inhibitor used to lower high cholesterol.
When will Alirocumab be back in stock in Canada?
Alirocumab has no active shortage; supply is normal per Health Canada reports.
Why is Alirocumab in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.